Ladenburg Thalmann Financial Services’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
Other funds holding KYNB
HA
EC
FCM
Ladenburg Thalmann Financial Services's KYNB Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services reduced its Kyntra Bio (KYNB) stake by 28% in Q4 2019, selling an estimated $39.8K and leaving 98 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #2976.
Ladenburg Thalmann Financial Services first reported a position in KYNB in Q1 2015 and has held it in 20 quarters since. The position peaked at $205K in Q1 2019. 213 funds tracked by Wall St. Rank hold KYNB as of Q4 2019.
- Ladenburg Thalmann Financial Services held 98 shares of Kyntra Bio worth $105K as of Q4 2019.
- Ladenburg Thalmann Financial Services sold 39 Kyntra Bio shares in Q4 2019, an estimated $39.8K.
- Kyntra Bio made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2976 holding.
- Ladenburg Thalmann Financial Services first reported a position in Kyntra Bio in Q1 2015 and has held it in 20 quarters since.
- Ladenburg Thalmann Financial Services's Kyntra Bio position peaked at $205K in Q1 2019.
- 213 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.